Bladder anatomy

  • Arterial supply: Superior and inferior vesical arteries (from internal iliac artery)
  • Venous return: Vesical venous plexus (will see when bladder is lifted) -> internal iliac veins
  • Nerve (sympathetic): sup/inf hypogastric plexus
  • Nerve (parasympathetic): inf hypogastric plexus, pelvic splanchnic n.
  • Lymphatic drainage
    • Level I: interal iliac, obturator, external iliac
    • Level II: common iliac, presacral
      • 7% of the time bladder cancer can skip to level 2 without level 1 involvement
    • Level III: para-aortic, interaortocaval, paracaval
      • Generally have level I/II involvement as well

Radical cystectomy: Gold standard for muscle-invasive, non-metastatic bladder UC.

  • Removal of bladder and pelvic lymph nodes, with prostate+seminal vesicles in men, or +/- anterior vagina+uterus/fallopians/ovaries in women
  • Indications
    • Muscle-invasive cancer (T2 and above)
    • Recurrent non-muscle-invasive (failed resection/intravesical BCG, esp. if failed 2x)
    • High-grade T1 lesions a/w CIS/LVI/variant histologies (if long life expectancy, or multiple/large tumors)
  • Partial cystectomy can be performed if able to achieve negative margins (eg bladder dome or diverticulum), no prior hx of bladder tumors, no prostate involvement
    • **hide**But prostate cancer found in 23-54% of RC specimens; 17-75% had UC involving prostate
    • **hide**Gynecologic UC involvement in < 5%
    • Not recommended if able to have RC
  • **hide**Intraoperative frozen-section of ureteral margin - negative margin after positive margin still had higher risk of upper tract recurrence; should still attempt for negative margin

Pelvic lymph node dissection (PLND) should be performed with radical and partial cystectomy.

  • Standard PLND - up to level I (external iliac, internal iliac, obturator)
  • Extended PLND - up to level II (common iliac, presacral)
  • Super-extended PLND - up to level III (para-aortic, interaortocaval, paracaval)
    • Extended/super-extended PLND traditionally thought to improve survival by removing more micrometastatic disease, but recent (2023) SWOG 1011 randomized phase 3 trial showed no survival benefit to extended dissection; increased toxicity (54% vs 44% adverse events, 7% vs 2% death within 90 days).
  • Goal - 25-node minimum (75% chance of identifying 1+ LN metastasis; retrospective data)
  • 15% of T2 (presumed N0) disease undergoing cystectomy will have node-positive disease
Superior

Limited - common iliac
Extended (standard) - aortic bifurcation/where ureters cross
Super-extended - IMA 

Inferior inguinal/Cooper's ligament
Medial bladder/internal iliac
Lateral pelvic side wall, genitofemoral nerve
Anterior external iliac vein
Posterior obturator nerve (extended - down to pelvic floor)

PLND borders
 

Female anatomy - uterine artery

Sexual and Urinary Function following Cystectomy in Women - American  Urological Association

 

Internal iliac artery anatomy

Internal Iliac Artery - M1 Perineum - YouTube

 Urinary diversion:

  • No overall difference in QoL between methods, but limited data.
  • Bowel prep (e.g. Nichols prep) not necessary if using small bowel.
  • Ideal reservoir is
    • Non-refluxing
      • Refluxing ureteral anastomosis has lower stricture rate, but recommend anti-refluxing for continent diversion
      • In intermediate term, anti-refluxing does not appear to be necessary for upper tract preservation or UTI prevention
    • Low-pressure (detubularize the bowel)
    • Continent
    • Non-absorptive
  • Bricker (independent ureteral anastomosis) vs. Wallace (ureters spatulated and anastomosed together to ileum) : no difference in stricture rate.
  • If using ileum, start ~15-20 cm proximal to ileocecal valve to preserve salt absorption.
Cutaneous urinary diversion (ileal conduit)

Non-continent
Take ~18 cm intestine (enough to stretch to abdomen)

Complications: parastomal hernia, stomal stenosis

  • Stoma location - identify pre-op, avoid skin creases, within rectus muscle to prevent stomal hernia, below belt line to conceal pouch
Catheterizable urinary diversion (Indiana pouch)

Continent - Ileocecal valve provides the continence mechanism; use R colon as the reservoir (perform pre-op colonoscopy)

28 cm of R colon (detubularize into pouch), ~10 cm of ileum (taper into cath channel)

Contraindications to continent diversion

  • Cr > 1.7-2.2 (or eGFR < 40, renal function -> increased metabolic acidosis)
  • Liver failure
  • Unable to self-catheterize (10-50% men, 30-60% women)
  • Chronic bowel disease (e.g. IBD)

Neobladder specific contradindications

  • Urethral stricture
  • Positive intraoperative urethral margin
    • If prostatic urethral involvement can still consider neobladder (since prostate will be removed)
  • Pelvic radiation (can consider in select cases) (can have radiation after neobladder)
Neobladder

Continent - void per urethra
Take ~60 cm intestine

Complications:

  • Urinary incontinence - continence comes from rhabdosphincter/pudendal nerve
  • Daytime incontinence - 10-20% after 6 mo
  • Nighttime incontinence - 20-50%
  • Urinary retention - 4-10% men, 20-60% women
Ureterosigmoidostomy Continent diversion to GI tract Increased risk of colon cancer (urine is caustic) 2.5% at ~26 yrs. Begin colonoscopies at 10 years.
Also increased risk with enterocystoplasty (augmentation), but not with other diversions.

Complications of bowel in the urinary tract

  • Depends on length of conduit, segment of intestine, duration of contact (continent vs non-continent)
  K Cl pH  Other
Colon/ileum acidosis Compensates with bone buffer -> demineralization, growth impairment
Treat with K citrate, or chloride blockers (chlorpromazine, nicotinic acid)
Ileal resection: hyperoxaluria/stones, B12 deficiency (>5 years post-op. Start checking at 1 year; replete with sublingual B12)
Start ~15-20 cm proximal to ileocecal valve to preserve salt absorption. Spina bifida patients need ileocecal valve for fecal continence
Kidneys eliminate acid by ammonium excretion, but colon/ileum reabsorbs ammonium
(watch out if liver disease)
Stomach

alkalosis

Treat with H2 blockers, PPI
Hematuria-dysuria - acid irritates bladder
Alkaline urine stimulates gastrin secretion -> ulcers
Use for: pelvic radiation (far from field), renal insufficiency (no acidosis), liver disease (no hyperammonemia)

Gastric secretions (K, HCl) lost in urine

Jejunum acidosis
(hyponatremic)
Treat with NaCl hydration; correct hyperkalemic acidosis; long-term oral NaCl
Secretes NaCl, absorbs H, K (exacerbated with TPN)

Complications of conduit diversion (10-20%)

  • Bowel - obstruction, fistula, abscess
  • Renal failure
  • Recurrent UTI (bowel is chronically colonized), pyelonephritis
  • Parastomal hernia or stomal stenosis
  • Anastomotic strictures
  • Stones from UTI, mucus, acidosis/hypokalemia, dehydration from diarrhea
    • Staple lines can be nidus for stones
    • Mucus: colon > ileum > stomach; increased with dairy
    • Diarrhea after bowel resection; treat with cholestyramine
  • Renally excreted drugs can be reabsorbed
    • Methotrexate - drain diversion during chemo; alkalinize the urine and hydrate
  • Interesting technical article on PCNUs for conduit leaks

ERAS protocol (Early Recovery after Surgery) - hopsital stay 3-5 d instead of 8-10; early fluids/feeding. Entereg/almivopan - blocks narcotic effect on bowel

Stanford: ***update with new pathway

  • Pre-op abx: cefoxitin
  Diet Pain Activity Other
POD 0 clears
IVF
Tylenol, toradol, gaba, oxy
Entereg
OOB & amb, chair x 30 min Neobladder: start q4h irrigation
POD 1 PS1
SLIV
Stop Entereg when having BMs chair x 6-8 hrs, amb x 4-5 Ileal conduit: stoma visits
POD 2 reg   amb x 4-5  
POD 3-4
home
     

Stents out by POD 4 (Skinner)

Switch heparin to lovenox (30 d) POD 3-4

  • Eliquis 2.5 mg BID non-inferior to lovenox, no additional bleeding risk, should have better compliance (JU paper)

If neobladder, get urine culture before going home in case of later infection

  • If going home with JP drain - remove if < 100 ml/day

PAVA:

  • Pre-op abx: cefoxitin
  • Similar to Stanford, just 1 day slower for diet
  Diet Pain Other
POD 0 sips of clears
IV NS@125
APAP, toradol, prn oxy Neobladder: start q4h irrigation
POD 1 clears   Ileal conduit: stoma visits
POD 2 fulls
SLIV
  Lovenox teaching
POD 3-4
 
regular   Stoma cath out POD4
  • Ureteral stents x 1 week

Post cystectomy surveillance

  • Years 1-2:
    • LFTs/BMP q3-6 mo
    • CT IVP q3-6 mo
    • CXR/CT chest q3-6 mo
    • Urine cytology q6mo
  • Years 3-5: LFTs + B12, CT IVP, CXR/CT chest annually
  • Years 5-10: B12, renal US to monitor for hydronephrosis annually
  • PET/CT only if metastasis suspected

author: admin | last edited: Oct. 7, 2024, 10:30 a.m. | pk: 13

  1. Ileal Conduit as the Standard for Urinary Diversion After Radical Cystectomy for Bladder Cancer

Video Lectures: 

Guidelines:

AUA Core Curriculum (may require login):